CL Batlevi, E Matsuki, RJ Brentjens… - Nature reviews Clinical …, 2016 - nature.com
The success of the anti-CD20 monoclonal antibody rituximab in the treatment of lymphoid
malignancies provided proof-of-principle for exploiting the immune system therapeutically …